SOPHARMA AD - Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 1 / 2022

Date of issue: 2022-01-06

Short name of the issuer

SOPHARMA AD

Subject

Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, January 6, 2022 – According to the requirements of Art. 100t of LPOS and in connection with Art. 114, para. 9 of the Law on Public Offering of Securities, “Sopharma” AD (SFA: BSE-Sofia, SPH: Warsaw Stock Exchange) announces that today, according to a decision of the Board of Directors dated December 21, 2021, the company concluded the following transactions falling within the scope of Art. 114, para. 2 of the LPOS:

Annexes

File Description

SFA_2022_114_Telekomplekt_EN_espi.pdf Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2022-01-06 Ognian Donev Executive Director